This review highlights the need for non-invasive early diagnostic tools and summarizes current management strategies for coronary allograft vasculopathy in pediatric heart transplant recipients.
Answers are grounded in this paper and cite their sources.
May aid early pediatric CAV detection via non-invasive tools; leaves open optimal management pending prospective validation.
Coronary allograft vasculopathy remains one of the leading causes of death beyond the first year post transplant. As a result of denervation following transplantation, patients lack ischaemic symptoms and presentation is often late when the graft is already compromised. Current diagnostic tools are rather invasive, or in case of angiography, significantly lack sensitivity. Therefore a non-invasive tool that could allow early diagnosis would be invaluable.This paper review the disease form its different diagnosis techniques,including new and less invasive diagnostic tools to its pharmacological management and possible treatments.
No takes yet. Share an insight, caveat, or question.
Nathalie Dedieu (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: